Royal Bank of Canada
CYTXW

Royal Bank of Canada’s Cytori Therapeutics Inc Warrant CYTXW Stock Holding History

Royal Bank of Canada’s Portfolio CYTXW Stock Details CYTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50
Closed – – 7254
2017
Q4 		$0 Hold
50
– – ﹤0.01% 7359
2017
Q3 		$0 Sell
50
-583
-92% -$56 ﹤0.01% 7350
2017
Q2 		$0 Hold
633
– – ﹤0.01% 7113
2017
Q1 		$0 Hold
633
– – ﹤0.01% 7071
2016
Q4 		$0 Hold
633
– – ﹤0.01% 7003
2016
Q3 		$1K Sell
633
-250
-28% -$207 ﹤0.01% 6355
2016
Q2 		$1K Buy
+883
New +$593 ﹤0.01% 6322

Other funds holding CYTXW

Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Royal Bank of Canada's CYTXW Position: Q1 2018 in Review

Royal Bank of Canada sold out of Cytori Therapeutics Inc Warrant (CYTXW) in Q1 2018, closing a stake of 50 shares.

Royal Bank of Canada first reported a position in CYTXW in Q2 2016 and held it in 7 quarters. The position peaked at $1K in Q3 2016. 2 funds tracked by Wall St. Rank hold CYTXW as of Q1 2018.

  • Royal Bank of Canada reported no remaining Cytori Therapeutics Inc Warrant position as of Q1 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 50 Cytori Therapeutics Inc Warrant shares in Q1 2018.
  • Royal Bank of Canada first reported a position in Cytori Therapeutics Inc Warrant in Q2 2016 and held it in 7 quarters.
  • Royal Bank of Canada's Cytori Therapeutics Inc Warrant position peaked at $1K in Q3 2016.
  • 2 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Warrant as of Q1 2018.

Based on Royal Bank of Canada's 13F filing for Q1 2018, filed 15 May 2018.